PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM

Contract Award won by THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER
$149,995,000
RecipientTHE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER UEI S3GMKS8ELA16
Award ID75N91024D00004
Award amount$149,995,000
Award type—
Awarding agencyDepartment of Health and Human Services — National Institutes of Health
NAICS541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSCAN12
Start dateJan 25, 2024
End date—
Place of performance—
Record updatedJun 25, 2024

View the official award record

More awards won by THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER

NATIONAL CORD BLOOD INVENTORY
Department of Health and Human Services · $30,543,799 · Sep 27, 2019
TAS::75 0350::TAS - PROVIDE FOR THE COLLECTION AND MAINTENANCE OF GENETICALLY DIVERSE, HIGH-QUALITY UMBILICAL CORD BLOOD UNITS FOR INCLUSION IN THE NATIONAL CORD BLLOD INVENTORY
Department of Health and Human Services · $30,351,425 · Sep 8, 2010
OPERATION AND MAINTENANCE OF THE CHIMPANZEE CARE CENTER (CCC)
Department of Health and Human Services · $3,477,589 · Dec 1, 2020
IGF::OT::IGF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF 4-HYDROXYTAMOXIFEN TOPICAL GEL IN WOMEN WITH MAMMOGRAPHICALLY DENSE BREASTS
Department of Health and Human Services · $2,281,843 · Sep 19, 2016
OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
Department of Health and Human Services · $1,872,307 · Sep 10, 2019

Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.

Search open bids